STUART LEVITZ

Summary

Affiliation: University of Massachusetts Medical School
Country: USA

Publications

  1. pmc Effect of differential N-linked and O-linked mannosylation on recognition of fungal antigens by dendritic cells
    Jennifer S Lam
    Department of Medicine and the Immunology Training Program, Boston University School of Medicine, Boston, Massachusetts, United States of America
    PLoS ONE 2:e1009. 2007
  2. pmc Cooperative stimulation of dendritic cells by Cryptococcus neoformans mannoproteins and CpG oligodeoxynucleotides
    Jennifer M Dan
    Department of Microbiology and Immunology Training Program, Boston University School of Medicine, Boston, Massachusetts, United States of America
    PLoS ONE 3:e2046. 2008
  3. pmc Beyond empiricism: informing vaccine development through innate immunity research
    Stuart M Levitz
    Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA
    Cell 148:1284-92. 2012
  4. doi request reprint Th17 cells bounce off the fungal wall
    Stuart M Levitz
    University of Massachusetts Medical School, 364 Plantation Street, LRB317, Worcester, MA 01605, USA
    Cell Host Microbe 5:311-3. 2009
  5. pmc Isolation and purification of antigenic components of Cryptococcus
    Karen L Wozniak
    Department of Medicine and Microbiology, University of Massachusetts Medical School, Worcester, Massachusetts, USA
    Methods Mol Biol 470:71-83. 2009

Research Grants

  1. IMMUNE RESPONSE TO CRYPTOCOCCAL INFECTIONS
    Stuart M Levitz; Fiscal Year: 2010
  2. Model Vaccines Exploiting Fungal Mannosylation
    STUART LEVITZ; Fiscal Year: 2007
  3. IMMUNE RESPONSE TO CRYPTOCOCCAL INFECTIONS
    STUART LEVITZ; Fiscal Year: 2009
  4. IMMUNE RESPONSE TO CRYPTOCOCCAL INFECTIONS
    STUART LEVITZ; Fiscal Year: 2005
  5. MACROPHAGE INTERACTIONS WITH C. NEOFORMANS
    STUART LEVITZ; Fiscal Year: 2001
  6. Model Vaccines Exploiting Fungal Mannosylation
    STUART LEVITZ; Fiscal Year: 2006
  7. IMMUNE RESPONSE TO CRYPTOCOCCAL INFECTIONS
    STUART LEVITZ; Fiscal Year: 2004
  8. MACROPHAGE INTERACTIONS WITH C. NEOFORMANS
    STUART LEVITZ; Fiscal Year: 2004
  9. MACROPHAGE INTERACTIONS WITH C. NEOFORMANS
    STUART LEVITZ; Fiscal Year: 2003
  10. 6th International Conf. on Cryptococcus & Cryptococcosis
    STUART LEVITZ; Fiscal Year: 2005

Collaborators

Detail Information

Publications9

  1. pmc Effect of differential N-linked and O-linked mannosylation on recognition of fungal antigens by dendritic cells
    Jennifer S Lam
    Department of Medicine and the Immunology Training Program, Boston University School of Medicine, Boston, Massachusetts, United States of America
    PLoS ONE 2:e1009. 2007
    ..In order to gain insight into the mechanisms responsible for this observation, the present study examined the cellular uptake of the mannosylated and deglycosylated recombinant proteins...
  2. pmc Cooperative stimulation of dendritic cells by Cryptococcus neoformans mannoproteins and CpG oligodeoxynucleotides
    Jennifer M Dan
    Department of Microbiology and Immunology Training Program, Boston University School of Medicine, Boston, Massachusetts, United States of America
    PLoS ONE 3:e2046. 2008
    ....
  3. pmc Beyond empiricism: informing vaccine development through innate immunity research
    Stuart M Levitz
    Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA
    Cell 148:1284-92. 2012
    ..Incorporating these adjuvants and delivery systems in vaccines can beneficially alter the quantitative and qualitative nature of the adaptive immune response, resulting in enhanced protection...
  4. doi request reprint Th17 cells bounce off the fungal wall
    Stuart M Levitz
    University of Massachusetts Medical School, 364 Plantation Street, LRB317, Worcester, MA 01605, USA
    Cell Host Microbe 5:311-3. 2009
    ....
  5. pmc Isolation and purification of antigenic components of Cryptococcus
    Karen L Wozniak
    Department of Medicine and Microbiology, University of Massachusetts Medical School, Worcester, Massachusetts, USA
    Methods Mol Biol 470:71-83. 2009
    ..In contrast, MPs have been identified as key antigens that stimulate T-cell responses. Purification of GXM and MP should assist investigators studying the antigenic, biochemical, and virulence properties of Cryptococcus species...

Research Grants37

  1. IMMUNE RESPONSE TO CRYPTOCOCCAL INFECTIONS
    Stuart M Levitz; Fiscal Year: 2010
    ..As broad concepts are being studied, the knowledge gained should also be applicable to the development of vaccines against other infectious diseases. ..
  2. Model Vaccines Exploiting Fungal Mannosylation
    STUART LEVITZ; Fiscal Year: 2007
    ....
  3. IMMUNE RESPONSE TO CRYPTOCOCCAL INFECTIONS
    STUART LEVITZ; Fiscal Year: 2009
    ..As broad concepts are being studied, the knowledge gained should also be applicable to the development of vaccines against other infectious diseases. ..
  4. IMMUNE RESPONSE TO CRYPTOCOCCAL INFECTIONS
    STUART LEVITZ; Fiscal Year: 2005
    ..abstract_text> ..
  5. MACROPHAGE INTERACTIONS WITH C. NEOFORMANS
    STUART LEVITZ; Fiscal Year: 2001
    ..Completion of these aims will add significantly to our understanding of the immunopathogenesis of cryptococcosis and may suggest novel approaches to the prevention and treatment of this life-threatening mycosis. ..
  6. Model Vaccines Exploiting Fungal Mannosylation
    STUART LEVITZ; Fiscal Year: 2006
    ....
  7. IMMUNE RESPONSE TO CRYPTOCOCCAL INFECTIONS
    STUART LEVITZ; Fiscal Year: 2004
    ..abstract_text> ..
  8. MACROPHAGE INTERACTIONS WITH C. NEOFORMANS
    STUART LEVITZ; Fiscal Year: 2004
    ..Completion of these aims will add significantly to our understanding of the immunopathogenesis of cryptococcosis and may suggest novel approaches to the prevention and treatment of this life-threatening mycosis. ..
  9. MACROPHAGE INTERACTIONS WITH C. NEOFORMANS
    STUART LEVITZ; Fiscal Year: 2003
    ..Completion of these aims will add significantly to our understanding of the immunopathogenesis of cryptococcosis and may suggest novel approaches to the prevention and treatment of this life-threatening mycosis. ..
  10. 6th International Conf. on Cryptococcus & Cryptococcosis
    STUART LEVITZ; Fiscal Year: 2005
    ..neoformans and Cryptococcosis and to recommend new and future research initiatives and prioritize these. ..
  11. Model Vaccines Exploiting Fungal Mannosylation
    STUART LEVITZ; Fiscal Year: 2005
    ....
  12. IMMUNE RESPONSE TO CRYPTOCOCCAL INFECTIONS
    STUART LEVITZ; Fiscal Year: 2007
    ..abstract_text> ..
  13. IMMUNE RESPONSE TO CRYPTOCOCCAL INFECTIONS
    STUART LEVITZ; Fiscal Year: 2006
    ..abstract_text> ..
  14. Model Vaccines Exploiting Fungal Mannosylation
    STUART LEVITZ; Fiscal Year: 2009
    ....
  15. IMMUNE RESPONSE TO CRYPTOCOCCAL INFECTIONS
    STUART LEVITZ; Fiscal Year: 2003
    ..abstract_text> ..
  16. IMMUNE RESPONSE TO CRYPTOCOCCAL INFECTIONS
    STUART LEVITZ; Fiscal Year: 2002
    ..To test the recombinant proteins as vaccine candidates. Mice will be immunized with the recombinant proteins generated in specific aim 2 and then challenged with C. neoformans using intratracheal and intravenous models of infection. ..
  17. MACROPHAGE INTERACTIONS WITH C NEOFORMANS
    STUART LEVITZ; Fiscal Year: 2000
    ....
  18. IMMUNE RESPONSE TO CRYPTOCOCCAL INFECTIONS
    STUART LEVITZ; Fiscal Year: 2000
    ..To test the recombinant proteins as vaccine candidates. Mice will be immunized with the recombinant proteins generated in specific aim 2 and then challenged with C. neoformans using intratracheal and intravenous models of infection. ..
  19. MACROPHAGE INTERACTIONS WITH C. NEOFORMANS
    STUART LEVITZ; Fiscal Year: 2001
    ..Completion of these aims will add significantly to our understanding of the immunopathogenesis of cryptococcosis and may suggest novel approaches to the prevention and treatment of this life-threatening mycosis. ..
  20. IMMUNE RESPONSE TO CRYPTOCOCCAL INFECTIONS
    STUART LEVITZ; Fiscal Year: 2001
    ..To test the recombinant proteins as vaccine candidates. Mice will be immunized with the recombinant proteins generated in specific aim 2 and then challenged with C. neoformans using intratracheal and intravenous models of infection. ..
  21. MACROPHAGE INTERACTIONS WITH C. NEOFORMANS
    STUART LEVITZ; Fiscal Year: 2002
    ..Completion of these aims will add significantly to our understanding of the immunopathogenesis of cryptococcosis and may suggest novel approaches to the prevention and treatment of this life-threatening mycosis. ..
  22. MACROPHAGE INTERACTIONS WITH C NEOFORMANS
    STUART LEVITZ; Fiscal Year: 1999
    ....
  23. Model Vaccines Exploiting Fungal Mannosylation
    STUART LEVITZ; Fiscal Year: 2006
    ....
  24. IMMUNE RESPONSE TO CRYPTOCOCCAL INFECTIONS
    STUART LEVITZ; Fiscal Year: 2006
    ..abstract_text> ..
  25. IMMUNE RESPONSE TO CRYPTOCOCCAL INFECTIONS
    STUART LEVITZ; Fiscal Year: 1999
    ..To test the recombinant proteins as vaccine candidates. Mice will be immunized with the recombinant proteins generated in specific aim 2 and then challenged with C. neoformans using intratracheal and intravenous models of infection. ..
  26. MACROPHAGE INTERACTIONS WITH C. NEOFORMANS
    STUART LEVITZ; Fiscal Year: 2005
    ..Completion of these aims will add significantly to our understanding of the immunopathogenesis of cryptococcosis and may suggest novel approaches to the prevention and treatment of this life-threatening mycosis. ..